Per thor Straten

Publikation

Publikationer pr. år 1994 2009 2010 2011 2016 2018 2020

• 52 Tidsskriftartikel
• 4 Konferenceabstrakt i tidsskrift
• 4 Letter
• 4 Review
• 4 Mere
  • 3 Kommentar/debat
  • 1 Bidrag til bog/antologi

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2009

  CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53

  Sørensen, R. B., Andersen, R. S., Svane, I. M., Engell-Noerregaard, L., Hadrup, S. R., Balslev, E., Andersen, M. H. & thor Straten, P., 2009, I: Clinical Cancer Research. 15, 5, s. 1543-9 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cyclin B1 100%
  • Breast Neoplasms 48%
  • T-Lymphocytes 46%
  • Peptides 34%
  • Neoplasms 24%
  12 Citationer (Scopus)

• Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression"

  Sørensen, R. B., thor Straten, P. & Andersen, M. H., 2009, I: Journal of Immunology. 183, 10, s. 6040 1 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  2 Citationer (Scopus)

• Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

  Hofmann, U. B., Voigt, H., Andersen, M. H., Straten, P. T., Becker, J. C. & Eggert, A. O., 2009, I: European Journal of Immunology. 39, 5, s. 1419-24 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Survivin 100%
  • Epitopes 71%
  • Vaccination 55%
  • Neoplasms 26%
  • Peptides 26%
  16 Citationer (Scopus)

• Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

  Andersen, M. H., Sørensen, R. B., Brimnes, M. K., Svane, I. M., Becker, J. C. & thor Straten, P., 2009, I: Journal of Clinical Investigation. 119, 8, s. 2245-56 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Heme Oxygenase-1 100%
  • Regulatory T-Lymphocytes 84%
  • T-Lymphocytes 52%
  • CD8 Antigens 29%
  • Neoplasms 27%
  58 Citationer (Scopus)

• Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

  Hofmeister-Mueller, V., Vetter-Kauczok, C. S., Ullrich, R., Meder, K., Lukanidin, E., Broecker, E-B., Straten, P. T., Andersen, M. H., Schrama, D. & Becker, J. C., 2009, I: Cancer Immunology, Immunotherapy. 58, 8, s. 1265-73 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • HLA-A1 Antigen 100%
  • Melanoma 51%
  • Epitopes 42%
  • Peptides 39%
  • T-Lymphocytes 23%
  2 Citationer (Scopus)

• Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709)

  Køllgaard, T., Duval, L., Schmidt, H., Kaltoft, K., Seremet, T., Andersen, M. H., Maase, H. V. D., Straten, P. T. & Hadrup, S. R., 2009, I: Cytotherapy. 11, 5, s. 631-41 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Immunologic Monitoring 100%
  • T-Cell Antigen Receptor 78%
  • HLA-A2 Antigen 52%
  • T-Lymphocytes 47%
  • Cell Line 45%
  3 Citationer (Scopus)

• Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56

  Baek Sørensen, R., Faurschou, M., Troelsen, L., Schrama, D., Jacobsen, S., Becker, J. C., Thor Straten, P., Andersen, M. H., Baek Sørensen, R., Faurschou, M., Troelsen, L., Schrama, D., Jacobsen, S., Becker, J. C., Thor Straten, P. & Andersen, M. H., 1 aug. 2009, I: Journal of Investigative Dermatology. 129, 8, s. 1992-9 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • human TRIM68 protein 100%
  • Inhibitor of Apoptosis Proteins 53%
  • Cytotoxic T-Lymphocytes 41%
  • Epitope 39%
  • Epitopes 33%
  7 Citationer (Scopus)

• Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers

  Hadrup, S. R., Bakker, A. H., Shu, C. J., Andersen, R. S., van Veluw, J., Hombrink, P., Castermans, E., Thor Straten, P., Blank, C., Haanen, J. B., Heemskerk, M. H. & Schumacher, T. N., 2009, I: Nature Methods. 6, 7, s. 520-6 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Antigen 100%
  • Antigens 75%
  • T-Lymphocytes 73%
  • Epitope 60%
  • Major Histocompatibility Complex 48%
  200 Citationer (Scopus)

• Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

  Engell-Noerregaard, L., Hansen, T. H., Andersen, M. H., Thor Straten, P. & Svane, I. M., 2009, I: Cancer Immunology, Immunotherapy. 58, 1, s. 1-14 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dendritic Cells 100%
  • Melanoma 92%
  • Vaccination 89%
  • Vaccines 83%
  • Clinical Studies 77%
  152 Citationer (Scopus)

• The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag)

  Wenandy, L., Kollgaard, T., Letsch, A., Andersen, R. S., Stather, D., Seremet, T., Svane, I. M., Vindeløv, L., Andersen, M. H. & thor Straten, P., 2009, I: Leukemia. 23, 10, s. 1926-9 4 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  7 Citationer (Scopus)

• The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

  Sørensen, R. B., Berge-Hansen, L., Junker, N., Hansen, C. A., Hadrup, S. R., Schumacher, T. N. M., Svane, I. M., Becker, J. C., thor Straten, P. & Andersen, M. H., 2009, I: PLoS ONE. 4, 9, s. e6910

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • indoleamine 2,3-dioxygenase 100%
  • T-cells 87%
  • immune response 80%
  • Indoleamine-Pyrrole 2,3,-Dioxygenase 80%
  • Immune System 77%
  55 Citationer (Scopus)

• The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

  Sørensen, R. B., Junker, N., Kirkin, A., Voigt, H., Svane, I. M., Becker, J. C., thor Straten, P. & Andersen, M. H., 2009, I: Cancer Immunology, Immunotherapy. 58, 5, s. 665-75 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • HLA-A2 Antigen 100%
  • Epitopes 62%
  • Melanoma 60%
  • T-Lymphocytes 45%
  • Cell Line 43%
  10 Citationer (Scopus)

• Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination

  Kyte, J. A., Trachsel, S., Risberg, B., thor Straten, P., Lislerud, K. & Gaudernack, G., 2009, I: Cancer Immunology, Immunotherapy. 58, 10, s. 1609-26 18 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cancer Survivors 100%
  • Vaccination 73%
  • Clone Cells 58%
  • Cytokines 56%
  • T-Lymphocytes 56%
  41 Citationer (Scopus)
• 2008

  Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue

  Schrama, D., Voigt, H., Eggert, A. O., Xiang, R., Zhou, H., Schumacher, T. N., Andersen, M. H., thor, S. P., Reisfeld, R. A. & Becker, J. C., 2008, I: Cancer Immunology, Immunotherapy. 57, 1, s. 85-95 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  32 Citationer (Scopus)

• Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a 'good' mHag?

  Kollgaard, T., Hadrup, S. R., Petersen, S. L., Holten-Andersen, M. N., Spierings, E., Vindeløv, L., Thor Straten, E. P. & Masmas, T. N., 2008, I: Leukemia. 22, 10, s. 1948-1951 3 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  2 Citationer (Scopus)
• 2006

  Reactivity of naive CD4+CD25- T cells against gut microflora in healthy mice

  Gad, M., Lundsgaard, D., Kjellev, S., Kristensen, N. N., Seremet, T., Straten, P. T. & Claesson, M. H., 2006, I: International Immunology. 18, 5, s. 817-25 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastrointestinal Microbiome 100%
  • T-Lymphocytes 62%
  • T-Lymphocyte Subsets 35%
  • Thymus Gland 32%
  • Antigens 32%
  8 Citationer (Scopus)
• 2005

  Towards discovery-driven translational research in breast cancer

  Celis, J. E., Moreira, J. M. A., Gromova, I., Cabezon, T., Ralfkiaer, U., Guldberg, P., Thor Straten, P., Mouridsen, H., Friis, E., Holm, D., Rank, F. & Gromov, P., 1 jan. 2005, I: FEBS Journal. 272, 1, s. 2-15 14 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Translational Medical Research 100%
  • Marker 77%
  • Breast Neoplasms 56%
  • Genomics 44%
  • Systems Biology 26%
  48 Citationer (Scopus)
• 1994

  Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions

  Schøller, J., thor Straten, P., Jakobsen, A. B., Siim, E., Dahlström, K., Drzewiecki, K. T. & Zeuthen, J., 1 okt. 1994, I: Cancer Immunology, Immunotherapy. 39, 4, s. 239-48 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Antigen Receptors, T-Cell, alpha-beta 100%
  • HLA-A1 Antigen 77%
  • Melanoma 60%
  • Lymphocytes 50%
  • varespladib methyl 33%
  21 Citationer (Scopus)